
Biophytis SA BPTS
Annual report 2023
added 12-27-2025
Biophytis SA ROCE Ratio 2011-2026 | BPTS
Annual ROCE Ratio Biophytis SA
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -325.06 | 571.5 | -102.08 | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 571.5 | -325.06 | 48.12 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
-91.24 | $ 2.68 | 1.13 % | $ 207 M | ||
|
AgeX Therapeutics
AGE
|
-180.78 | - | -10.17 % | $ 12.2 K | ||
|
Ascendis Pharma A/S
ASND
|
-45.89 | $ 213.28 | 1.91 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.21 | - | $ 7.72 B | ||
|
Autolus Therapeutics plc
AUTL
|
-161.2 | $ 1.95 | -2.5 % | $ 498 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
-92.73 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-531.85 | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | ||
|
AIkido Pharma
AIKI
|
-28.92 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-115.03 | $ 4.71 | 18.34 % | $ 10.2 B | ||
|
Catalyst Biosciences
CBIO
|
424.75 | $ 10.94 | -1.17 % | $ 720 M | ||
|
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
-109.6 | $ 1.46 | 0.69 % | $ 16.7 M | ||
|
Cellectis S.A.
CLLS
|
-20.47 | $ 4.55 | 3.06 % | $ 116 M | ||
|
BioNTech SE
BNTX
|
-4.81 | $ 100.08 | 2.03 % | $ 27.2 B | ||
|
BioDelivery Sciences International
BDSI
|
19.77 | - | -4.8 % | $ 255 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.05 | $ 27.33 | -1.05 % | $ 1.32 B | ||
|
AVROBIO
AVRO
|
10.76 | - | 1083.1 % | $ 745 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
20.15 | $ 37.0 | 3.55 % | $ 3.82 B | ||
|
BeiGene, Ltd.
BGNE
|
-15.33 | - | 0.49 % | $ 251 B | ||
|
CorMedix
CRMD
|
-69.8 | $ 11.17 | -0.8 % | $ 569 M | ||
|
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
95.22 | $ 11.74 | 22.04 % | $ 759 M | ||
|
BioVie
BIVI
|
-95.03 | $ 1.35 | -2.88 % | $ 1.99 M | ||
|
Axon Enterprise
AXON
|
2.51 | $ 620.91 | -0.92 % | $ 47 B | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-12.81 | $ 2.83 | 4.04 % | $ 17.8 M | ||
|
AstraZeneca PLC
AZN
|
11.12 | $ 95.16 | 0.21 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | ||
|
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | ||
|
Berkeley Lights
BLI
|
-69.03 | - | -7.31 % | $ 87 M | ||
|
Brickell Biotech
BBI
|
-64.05 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
14.24 | $ 9.29 | -0.05 % | $ 1.5 B | ||
|
bluebird bio
BLUE
|
-125.56 | - | - | $ 546 M |